Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Wells

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Toxicology and Applied Pharmacology|July 1, 1988
Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strainsB M Lubek, P K Basu, P G Wells
Toxicology and Applied Pharmacology|November 1, 1992
Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferaseS M de Morais, S Y Chow, P G Wells
Gastroenterology|February 1, 1992
Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndromeS M de Morais, J P Uetrecht, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanolP G Wells, A Küpfer, J A Lawson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoinP M Kim, L M Winn, T Parman, et al.
Teratology|October 1, 1989
Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture modelM J Shanks, M J Wiley, S Kubow, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosingP G Wells, J Feely, G R Wilkinson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1988
Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbitsB M Lubek, M Avaria, P K Basu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2000
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesisC J Nicol, J Zielenski, L C Tsui, et al.
Journal of Adolescence|December 1, 1978
An adolescent unit assessed: attitudes to a treatment experience for adolescents and their familiesR M Jones, D J Allen, P G Wells, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Toxicology and Applied Pharmacology|July 1, 1988
Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strainsB M Lubek, P K Basu, P G Wells
Toxicology and Applied Pharmacology|November 1, 1992
Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferaseS M de Morais, S Y Chow, P G Wells
Gastroenterology|February 1, 1992
Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndromeS M de Morais, J P Uetrecht, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanolP G Wells, A Küpfer, J A Lawson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoinP M Kim, L M Winn, T Parman, et al.
Teratology|October 1, 1989
Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture modelM J Shanks, M J Wiley, S Kubow, et al.
Clinical Pharmacology and Therapeutics|May 1, 1983
Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosingP G Wells, J Feely, G R Wilkinson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1988
Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbitsB M Lubek, M Avaria, P K Basu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2000
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesisC J Nicol, J Zielenski, L C Tsui, et al.
Journal of Adolescence|December 1, 1978
An adolescent unit assessed: attitudes to a treatment experience for adolescents and their familiesR M Jones, D J Allen, P G Wells, et al.
Pageof 8